You are here

Article info

Article menu
Respiratory research
Original article
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Authors

  1. Correspondence to Dr Karl Yen, Genentech Inc, 1 DNA Drive, South San Francisco, CA 94080-4990, USA; yen.karl{at}gene.com
View Full Text

Citation

Hanania NA, Noonan M, Corren J, et al
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Thorax 2015;70:748-756.

Publication history

  • Received December 18, 2014
  • Revised April 10, 2015
  • Accepted May 4, 2015
  • First published May 22, 2015.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/